Search results
Found 9354 matches for
The University of Oxford and Bayer HealthCare have entered into a strategic research alliance in the area of gynaecological therapies. The multi-target collaboration focuses on endometriosis and uterine fibroids with the goal of discovering and developing innovative treatment options for these diseases. The alliance is for an initial period of two years, but is open for extension to up to five years.
©
Shutterstock
MuM-PreDiCT
With MuM-PreDiCT we aim to provide deeper understanding of what makes some pregnant women more likely to have two or more long-term health conditions and how this affects them and their children.
PURE-FIRST Study
Using 3D ultrasound volumes to obtain diagnostic 2D images during the first trimester.
FENOX Study
A study into the biology of uterine Fibroids and Endometriosis at Oxford University.